Revive Therapeutics Provides Update on Oral Thin Film Product with Psilocybin

    NEXT STORY
    Telo Genomics Announces the Final Assignment of Patents on Hematological Cancers, Liquid Biopsy and Alzheimer’s Disease
    PREV STORY
    Seasonal Probiotics Company Jetson Adds Leading Pediatrician and OBGYN to Advisory “Gut Council”
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Colchicine significantly reduces the risk of first and total ischemic cardiovascular events by 23% and 34% respectively in addition to standard of care in patients with a recent myocardial infarction (MI)

    author_avatar
    NASDAQ Market News

    Roxadustat Global Phase 3 Results for Treatment of Chronic Kidney Disease (CKD) Anemia to be Presented at American Society of Nephrology Kidney Week 2019

    author_avatar
    NASDAQ Market News

    Novartis receives EC Approval for Beovu®, a next-generation anti-VEGF treatment for wet AMD, a leading cause of blindness worldwide

    author_avatar
    NASDAQ Market News